Interested in seeing if you or a loved one qualifies for an Alzheimer’s disease (AD) clinical trial? Fill out the survey to see if you pre-qualify.
Now Is the Time to Act Against Alzheimer’s Disease.

Agitation develops in nearly 50% of patients with Alzheimer’s disease (AD),contributing to disease progression, poor quality of life, higher rates of mortality, and institutionalization.1 Additionally, agitation associated with AD contributes to heightened caregiver burnout, anxiety, and depression and a higher likelihood of institutionalizing their loved one.2 But help may be available in the form of potentially new care options. Every step forward starts with volunteers like you or your loved ones.
Why Caregivers and Loved Ones Should Explore Clinical Trials
| If you’re caring for someone with Alzheimer’s disease, you know how hard it can be to watch the person you love change. You want to do everything possible to help — and one of the steps you can take is to explore clinical trials. These research studies test different investigational treatments that could improve memory, thinking, and behavior. They offer access to expert care, regular monitoring, and investigational therapies. While there is currently no cure for Alzheimer’s, enrolling yourself or a loved one in a clinical trial helps advance the science in Alzheimer’s care. |


What Is Being tested?
The main purpose of an Agitation in Alzheimer’s disease clinical study is to evaluate the safety and efficacy of investigational treatments in AD patients, as well as how they interact with — and are processed by — the body.
What Does Agitation in Alzheimer’s Disease (AD) Look Like in Patients?
Symptoms may include:3
- Restlessness
- Irritability
- Pacing
- Yelling
- Sudden outbursts that can be triggered by confusion or changes in routine

What Does Current Treatment For Agitation in Alzheimer’s Look Like?
Agitation can be one of the toughest symptoms for caregivers to manage. People with Alzheimer’s may get angry, upset, pace, or yell for reasons that aren’t always clear.3 FDA-approved medication for treating agitation in Alzheimer’s does exist, but can potentially have serious side effects, both physical (such as increased risk of stroke or death and change in blood pressure) as well as behavioral, such as increased anxiety and suicidal ideation.4 Researchers are working on potential treatments for agitation in Alzheimer’s, and clinical trial data plays an important role in working towards different treatments and care options.

From the Community
“There are clinical trials out there. I don’t want to just sit here and let it overtake me, I want to feel like I’m battling back, even just a little bit.”Todd, FL
“If I have the opportunity to help myself and help other people who are dealing with my condition, if that’s the way I can contribute, sign me up.”Elizabeth, VA
“Without the first person with the first step, you never know what greater good could come.”Thomas, MD
Note: Testimonials provided by trial participants are personal experiences and do not necessarily represent the views of the trial sponsor. They are not a substitute for medical advice, and the results of the trial may vary based on individual circumstances. Always consult with your healthcare provider before making any medical decisions.
See If You Pre-Qualify
FREQUENTLY ASKED QUESTIONS
What are the benefits of participating in an Alzheimer’s disease clinical trial?
The information gathered from clinical studies may help identify potential treatment options in the future for people living with AD. Study participants are often connected to specialists who understand their situation and can help answer questions from patients or their loved ones. Participants in research studies should also expect a professional clinical environment during the trial.
Who may be a good candidate to apply for an Alzheimer’s disease clinical trial?
You may consider applying for a study if you or a loved one:
- Are at least 55 years of age, and no older than 90
- Have a doctor-confirmed diagnosis of Alzheimer’s disease via PET scan, bloodwork, or MRI of the brain
- Exhibit signs of memory loss, confusion, agitation, restlessness, hallucinations or delusions
- Have a person in your/your loved one’s life with whom you/they spend 10 or more hours per week with on a regular basis who is willing and able to attend study visits, oversee medications, and help provide assessments (such as a spouse, caregiver, or an adult child)
What will happen during a clinical trial for Alzheimer’s disease?
Most clinical trials will involve frontline screening to confirm that a potential patient is, in fact, a match for that study’s criteria. Once verified and the patient has signed an Informed Consent Form, which clearly provides the details and purpose of the study to that individual and what it involves, participants can expect to attend scheduled appointments at a participating clinical research site. They will also receive a study drug (also called an investigational medication) and undergo additional screening and follow-up monitoring.
Are there any costs to participate in a clinical research study?
There is no cost to participate in a clinical trial. Participants receive all study-related medical care and study medications for the duration of the study at no cost. Likewise in many instances, study participants may receive travel and meal reimbursement and compensation.
Are there any risks to participating in a clinical research study?
All investigational drugs and medical procedures come with a risk of side effects. Participants may potentially experience some discomfort or other reactions during or after a clinical trial. The study staff should explain these potential risks before participants decide whether to join the trial and help address any concerns they may have.
Can a person change their mind about participating in a clinical study?
Yes. Participation in clinical trials is entirely voluntary. Even if a study participant is already involved in a study, they may change their mind, leave, or remove consent at any time, for any reason.
What if I have more questions?
If you are interested in learning more, please contact us at any time. You may email us at help@clinicalenrollment.com.
Still Have Questions?
Contact us anytime at help@clinicalenrollment.com.
- Source: https://pmc.ncbi.nlm.nih.gov/articles/PMC8085397/
- Source: https://www.geron.org/News-Events/GSA-News/Press-Room/Press-Releases/publication-highlights-person-centered-approach-to-managing-agitation-in-alzheimers-disease
- Source: https://www.alz.org/help-support/caregiving/stages-behaviors/anxiety-agitation
- Source: https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/in-depth/alzheimers/art-20048103
- Source: https://www.rexulti.com/mdd/questions-answers